Timothy Robert Henrichs, the Chief Financial Officer of Neuraxis, Inc., has recently acquired 1,937 shares of the company's common stock. This transaction, filed with the SEC on October 8, 2026, is significant as it demonstrates Henrichs' confidence in the company's future prospects.
Neuraxis, Inc. operates in the electromedical and electrotherapeutic apparatus sector, a field that is witnessing rapid advancements and innovations. The company's recent stock transaction highlights the ongoing developments within this industry.
According to the SEC filing, Henrichs purchased the shares at a price of $4.84 each. Following this transaction, he now owns a total of 9,530 shares of Neuraxis. This increase in ownership may indicate his strong belief in the company's direction and performance.
The filing specifies that Henrichs is an officer of Neuraxis, confirming his role in the company's leadership. His recent acquisition could potentially inspire confidence among other investors and stakeholders in the company.
As of now, the filing does not indicate any further actions or future plans related to this transaction. However, the acquisition of shares by a key executive often leads to speculation about the company's upcoming strategies and performance.
Details of the Transaction
The SEC filing indicates that Henrichs acquired the shares on October 8, 2026, under the transaction code 'P', which signifies a purchase. This transaction is categorized as a direct ownership, meaning Henrichs holds the shares in his name rather than through a trust or other entity.
Background on Neuraxis, Inc.
Neuraxis, Inc., incorporated in Delaware, operates within the electromedical and electrotherapeutic apparatus sector, classified under the Standard Industrial Classification (SIC) code 3845. The company is headquartered at 11611 N. Meridian St, Suite 330, Carmel, Indiana, and has a fiscal year ending on December 31.
Contact Information
The business phone number for Neuraxis is (812) 689-0791, which may be useful for stakeholders seeking further information about the company's operations or Henrichs' recent stock acquisition.
While the filing provides insights into Henrichs' recent stock purchase, it does not elaborate on the company's current financial performance, strategic initiatives, or any upcoming products that may influence investor sentiment.